LncRNA GA-Binding Protein Transcription Factor Subunit Beta-1 Antisense RNA 1 Inhibits Renal Carcinoma Growth Through an MiR-1246/Phosphoenolpyruvate Carboxykinase 1 Pathway [Retraction]

Abstract

Gao S, Zhang F, Sun H, Yang X. Onco Targets Ther. 2020;13:6827–6836. The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised regarding the alleged duplication of images in Figures 2 and 4. Specifically: Figure 2D, panel 786-o Ad-Vector appears to have been duplicated with Figure 4D, panel 786-0 GABPB1-AS1+siPCK1. Figure 2D, panel 786-o Ad-GABPB1-AS1 appears to have been duplicated with Figure 4D, panel GABPB1-AS1. Figure 4D, panel GABPB1-AS1+siPCK1 appears to have been duplicated with Figure 4E, panel caki-1 Vector. The authors responded to our queries but were unable to provide a satisfactory explanation for the alleged duplication or adequate raw data relating to the study. The Editor determined the findings of the study were invalid and requested for the article to be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper

Keywords

• renal cell carcinoma
• gabpb1-as1
• mir-1246
• pck1